Ali Bidari

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 16

Top Topics

Neuropathic Pain

Prognostic Factors

Patient Reported Outcomes

Top Venues

European journal of haematology

Clinical rheumatology

ACR open rheumatology

BMC musculoskeletal disorders

This page only lists publications with an associated author ORCID identifier.

Publications

Banafshesh Ghavidel-Parsa, Ali Bidari
The crosstalk of the pathophysiologic models in fibromyalgia. Clinical rheumatology (2023)
Ali Bidari, Sara Asgarian, Arash Pour Mohammad, Delaram Naderi, Shiva Rahimipour Anaraki, Milad Gholizadeh Mesgarha, Mahya Naderkhani
Immune thrombocytopenic purpura secondary to COVID-19 vaccination: A systematic review. European journal of haematology (2022)
Faeze Gharibpoor, Banafshesh Ghavidel-Parsa, Nazila Sattari, Ali Bidari, Fatemeh Nejatifar, Ali Montazeri
Effect of vitamin B12 on the symptom severity and psychological profile of fibromyalgia patients; a prospective pre-post study. BMC rheumatology 6 (1) (2022)
Ali Bidari, Banafshesh Ghavidel-Parsa
Nociplastic pain concept, a mechanistic basis for pragmatic approach to fibromyalgia. Clinical rheumatology 41 (10) (2022)
Ali Bidari, Sara Asgarian, Arash Pour Mohammad, Delaram Naderi, Shiva Rahimipour Anaraki, Milad Gholizadeh Mesgarha, Mahya Naderkhani
Immune thrombocytopenic purpura secondary to COVID-19 vaccination: A systematic review. European journal of haematology 110 (4) (2022)
Ali Bidari, Sara Asgarian, Arash Pour Mohammad, Delaram Naderi, Shiva Rahimipour Anaraki, Milad Gholizadeh Mesgarha, Mahya Naderkhani
Immune thrombocytopenic purpura secondary to COVID-19 vaccination: A systematic review. European journal of haematology (2022)
Ali Bidari, Sara Asgarian, Arash Pour Mohammad, Delaram Naderi, Shiva Rahimipour Anaraki, Milad Gholizadeh Mesgarha, Mahya Naderkhani
Immune thrombocytopenic purpura secondary to COVID-19 vaccination: A systematic review. European journal of haematology (2022)
Ali Bidari, Sara Asgarian, Arash Pour Mohammad, Delaram Naderi, Shiva Rahimipour Anaraki, Milad Gholizadeh Mesgarha, Mahya Naderkhani
Immune thrombocytopenic purpura secondary to COVID-19 vaccination: A systematic review. European journal of haematology 110 (4) (2022)
Ali Bidari, Sara Asgarian, Arash Pour Mohammad, Delaram Naderi, Shiva Rahimipour Anaraki, Milad Gholizadeh Mesgarha, Mahya Naderkhani
Immune thrombocytopenic purpura secondary to COVID-19 vaccination: A systematic review. European journal of haematology 110 (4) (2022)
Banafshesh Ghavidel-Parsa, Ali Bidari
Reply. ACR open rheumatology 4 (7) (2022)
Ali Bidari, Banafshesh Ghavidel-Parsa, Faeze Gharibpoor
Comparison of the serum brain-derived neurotrophic factor (BDNF) between fibromyalgia and nociceptive pain groups; and effect of duloxetine on the BDNF level. BMC musculoskeletal disorders 23 (1) (2022)
Banafshesh Ghavidel-Parsa, Ali Bidari, Zahra Atrkarroushan, Mohammad-Javad Khosousi
Implication of the Nociplastic Features for Clinical Diagnosis of Fibromyalgia: Development of the Preliminary Nociplastic-Based Fibromyalgia Features (NFF) Tool. ACR open rheumatology 4 (3) (2021)
Banafshesh Ghavidel-Parsa, Ali Bidari, Ashkan Rahimi, Faeze Gharibpoor, Mohammad-Javad Khosousi
No effect of approved fibromyalgia drugs on the social pain (invalidation) contrary to physical pain: an open-label short-term randomized clinical trial. Clinical rheumatology (2021)
Banafshesh Ghavidel-Parsa, Ali Bidari, Sepehr Tohidi, Irandokht Shenavar Masooleh, Ehsan Kazemnezhad, Kazem Hosseini, Mohammad-Javad Khosousi
Implication of invalidation concept in fibromyalgia diagnosis. Clinical rheumatology 40 (6) (2021)
Faeze Gharibpoor, Elaheh Nasrollahzadeh, Banafshesh Ghavidel-Parsa, Mohammad Ebrahim Ghaffari, Ali Bidari
High cost of illness in fibromyalgia patients in Iran, irrespective of disease severity: A prospective cost study. International journal of rheumatic diseases 24 (5) (2021)
Banafshesh Ghavidel-Parsa, Ali Bidari
Two sides on the fibromyalgia coin: physical pain and social pain (invalidation). Clinical rheumatology 40 (3) (2020)